Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Raju Kucherlapati, Ph.D.
Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School

Welcome all attendees, discussing Personalized Medicine, what happened and looking forward — the potential of this approach to Medicine. Event organized with Partner, National Council Cancer Research. Organizing committee and Sponsors made the event possible.

AND

Scott Weiss, M.D., M.S.
Scientific Director, Partners Personalized Medicine;
Associate Director, Channing Laboratory, Professor of Medicine.

Victor Dzau, M.D. — ABSENT — By Voice addressing the Audience
President, Institute of Medicine

Advisor on Genomics – In 1996 returned from Stanford to Harvard. What role Genetics and Genomics will play in Medicine.

Boston is a very special place for that endeavor. Harvard allocated $100 Million to study this topic. 10th year of the Conference. I am 100 days at IOM, Genomics and personalized medicine (PM) and Translation Medicine are the center. Spin off in Software development to solicit application in PM. Scientists, payers, technologists — the economics of PM navigate the regulatory. Looking forward for the next 10 years in PM